SCHEMBL9764371

SCHEMBL9764371

Nc1c(Cl)cc(C(O)CN(CCCCCCOCCCCc2ccccc2)Cc2ccccc2)cc1Cl

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB2 P07550 2/20 0.41
KCNH2 Q12809 2/20 0.39
KDM4E B2RXH2 2/20 0.39
ADRB1 P08588 1/20 0.39
HTR1A P08908 1/20 0.39
CHRM5 P08912 1/20 0.39
ADRB3 P13945 1/20 0.39
DRD2 P14416 1/20 0.39
ADRA2B P18089 1/20 0.39
DRD4 P21917 1/20 0.39
SLC6A2 P23975 1/20 0.39
FPR3 P25089 1/20 0.39
ADRA1D P25100 1/20 0.39
HTR1D P28221 1/20 0.39
HTR1B P28222 1/20 0.39
HTR2A P28223 1/20 0.39
HTR2C P28335 1/20 0.39
SLC6A4 P31645 1/20 0.39
GPR183 P32249 1/20 0.39
HTR7 P34969 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9764456 0.96 ADRB2 (0.41) ADRB2KCNH2KDM4EADRB1HTR1A
SCHEMBL9764429 0.96 ADRB2 (0.41) ADRB2KCNH2KDM4EADRB1HTR1A
SCHEMBL10389958 0.93 ADRB2 (0.41) ADRB2KDM4EADRB1HTR1ASLC6A2
SCHEMBL10417482 0.93 SLC2A1 (0.39) ADRB2KCNH2KDM4EADRB1HTR1A
SCHEMBL9321535 0.91 MAOB (0.37) ADRB2KDM4EADRB1HTR1ASLC6A2
SCHEMBL9764301 0.91 NR1H3 (0.45) ADRB2KCNH2TSHRBCHENR1H3
SCHEMBL9764329 0.91 ADRB2 (0.39) ADRB2ADRB1SLC6A2SLC6A4SLC6A3
SCHEMBL9764389 0.91 ADRB2 (0.39) ADRB2KCNH2KDM4EADRB1MAPK1
SCHEMBL9324009 0.90 MAOB (0.39) KDM4EADRB1BCHENR1H3
SCHEMBL9764460 0.90 LTB4R (0.38) ADRB2KDM4EMEN1KMT2ABCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5006556-A Dichloroaniline derivatives for the therapy or prophylaxysis of a disease associated with reversible airway obstruction GLAXO GROUP LIMITED (GB) 1991-04-09 US disclosed
US-4943591-A TREATMENT OF ASTHMA AND BRONCHITIS GLAXO GROUP LIMITED (GB) 1990-07-24 US disclosed
EP-0181709-A1 Dichloroaniline Derivatives GLAXO GROUP LIMITED (GB) 1986-05-21 EP disclosed